Metastatic Castration Resistant
Showing 51 - 75 of >10,000
Prostate Cancer Metastatic Trial in New York, Knoxville (HB-302/HB-301 Alternating 2-Vector Therapy)
Recruiting
- Prostate Cancer Metastatic
- HB-302/HB-301 Alternating 2-Vector Therapy
-
New York, New York
- +1 more
Feb 1, 2023
Metastatic Castration-resistant Prostate Tumors Trial in Australia, Korea, Republic of, United States (JNJ-78278343, Cetrelimab)
Not yet recruiting
- Metastatic Castration-resistant Prostate Neoplasms
-
Sarasota, Florida
- +7 more
Apr 6, 2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Sipuleucel-T Injection
- (no location specified)
Nov 10, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Finland, Netherlands, United Kingdom (BAY3546828, BAY2616505,
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- BAY3546828
- +2 more
-
Helsinki, Finland
- +3 more
Sep 18, 2023
Metastatic Castration-resistant Prostate Cancer Trial in La Jolla (Cirmtuzumab)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
-
La Jolla, CaliforniaUniversity of California San Diego
May 22, 2022
Metastatic Castration-resistant Prostate Cancer Trial (TmPSMA-02)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- TmPSMA-02
- (no location specified)
Aug 3, 2022
Metastatic Castration-Resistant Prostate Cancer Patients Trial in Copenhagen (Irofulven, Prednisolone 10 mg)
Active, not recruiting
- Metastatic Castration-Resistant Prostate Cancer Patients
- Irofulven
- Prednisolone 10 mg
-
Copenhagen, DenmarkRigshospitalet, Dept. Of Oncology
Feb 1, 2023
Patients With Metastatic Castration-resistant Prostate Cancer Trial (177Lu-PSMA-617 PET scan)
Not yet recruiting
- Patients With Metastatic Castration-resistant Prostate Cancer
- 177Lu-PSMA-617 PET scan
- (no location specified)
Nov 13, 2023
Metastatic Castration Resistant Prostate Cancer Trial in India (Enzalutamide, Androgen deprivation therapy (ADT))
Active, not recruiting
- Metastatic Castration Resistant Prostate Cancer
- Enzalutamide
- Androgen deprivation therapy (ADT)
-
Ahmedabad, India
- +7 more
Jan 21, 2023
Prostatic Tumors, Castration-Resistant Trial in Brisbane ([212Pb]Pb-ADVC001)
Not yet recruiting
- Prostatic Neoplasms
- Castration-Resistant
-
Brisbane, Queensland, AustraliaRoyal Brisbane & Women's Hospital
Feb 9, 2023
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- +2 more
- 177Lu HTK03170
- 68Ga-HTK03149
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 28, 2022
Metastatic Castration-Resistant Prostate Cancer Trial (Talazoparib)
Available
- Metastatic Castration-Resistant Prostate Cancer
- (no location specified)
Dec 6, 2022
Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in
Recruiting
- Castration-Resistant Prostatic Cancer
- +4 more
- ARAT
- +2 more
-
Orange City, Florida
- +1 more
Nov 23, 2022
Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- HP518 - Dose Escalation
- HP518 -Dose Expansion
- (no location specified)
Dec 1, 2023
Metastatic Castration-Resistant Prostate Adenocarcinoma Trial in United States (CCW702)
Active, not recruiting
- Metastatic Castration-Resistant Prostate Adenocarcinoma
-
San Diego, California
- +4 more
Sep 29, 2022
Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)
Terminated
- Metastatic Castration Resistant Prostate Cancer
- Prostate Neoplasms
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 16, 2022
Metastatic Castration-resistant Prostate Cancer Trial in China (TQB3823 tablets, Abiraterone acetate tablets, prednisone acetate
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- TQB3823 tablets
- +2 more
-
Chongqing, Chongqing, China
- +4 more
Jun 1, 2022
Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Ovarian Carcinoma Trial in Ann Arbor
Recruiting
- Metastatic Breast Cancer
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Mar 31, 2022
Metastatic Prostate Adenocarcinoma, Castration-resistant Prostate Cancer, Prostate Cancer Trial in Boston (Neratinib)
Terminated
- Metastatic Prostate Adenocarcinoma
- +3 more
-
Boston, Massachusetts
- +2 more
Jul 18, 2022
Abiraterone Acetate in Indian Metastatic, Castration Resistant
Withdrawn
- Prostate Cancer
- Abiraterone Acetate
-
Bangalore, India
- +2 more
Aug 15, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Oslo (212Pb-NG001)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
-
Oslo, NorwayOslo University Hospital
Feb 13, 2023
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco (FOR46, Enzalutamide, Pegfilgrastim)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- FOR46
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 1, 2022
Castration Resistant Prostatic Cancer, Metastatic Prostate Cancer Trial in San Francisco (Pembrolizumab, Chemotherapy)
Active, not recruiting
- Castration Resistant Prostatic Cancer
- Metastatic Prostate Cancer
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 17, 2022